BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19641220)

  • 41. Fluorometric TLC assay for evaluation of protein kinase inhibitors.
    Viht K; Vaasa A; Raidaru G; Enkvist E; Uri A
    Anal Biochem; 2005 May; 340(1):165-70. PubMed ID: 15802142
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A homogeneous, high-throughput assay for phosphatidylinositol 5-phosphate 4-kinase with a novel, rapid substrate preparation.
    Davis MI; Sasaki AT; Shen M; Emerling BM; Thorne N; Michael S; Pragani R; Boxer M; Sumita K; Takeuchi K; Auld DS; Li Z; Cantley LC; Simeonov A
    PLoS One; 2013; 8(1):e54127. PubMed ID: 23326584
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of a High-Throughput Screening Assay to Identify Inhibitors of the Lipid Kinase PIP5K1C.
    Wright BD; Simpson C; Stashko M; Kireev D; Hull-Ryde EA; Zylka MJ; Janzen WP
    J Biomol Screen; 2015 Jun; 20(5):655-62. PubMed ID: 25534829
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of inhibitors for a virally encoded protein kinase by 2 different screening systems: in vitro kinase assay and in-cell activity assay.
    Mett H; Hölscher K; Degen H; Esdar C; De Neumann BF; Flicke B; Freudenreich T; Holzer G; Schinzel S; Stamminger T; Stein-Gerlach M; Marschall M; Herget T
    J Biomol Screen; 2005 Feb; 10(1):36-45. PubMed ID: 15695342
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of phosphocellulose paper-based screening of inhibitors of lipid kinases: case study with PI3Kβ.
    Yanamandra M; Kole L; Giri A; Mitra S
    Anal Biochem; 2014 Mar; 449():132-8. PubMed ID: 24380788
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Implications for selectivity of 3,4-diarylquinolinones as p38alphaMAP kinase inhibitors.
    Peifer C; Urich R; Schattel V; Abadleh M; Röttig M; Kohlbacher O; Laufer S
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1431-5. PubMed ID: 18207396
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interaction profiles of protein kinase-inhibitor complexes and their application to virtual screening.
    Chuaqui C; Deng Z; Singh J
    J Med Chem; 2005 Jan; 48(1):121-33. PubMed ID: 15634006
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screening for cell migration inhibitors via automated microscopy reveals a Rho-kinase inhibitor.
    Yarrow JC; Totsukawa G; Charras GT; Mitchison TJ
    Chem Biol; 2005 Mar; 12(3):385-95. PubMed ID: 15797222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-throughput screening of natural products for cancer therapy.
    Harvey AL; Cree IA
    Planta Med; 2010 Aug; 76(11):1080-6. PubMed ID: 20635309
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-throughput kinase assay based on surface plasmon resonance suitable for native protein substrates.
    Takeda H; Fukumoto A; Miura A; Goshima N; Nomura N
    Anal Biochem; 2006 Oct; 357(2):262-71. PubMed ID: 16920059
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discovery of indenopyrazoles as EGFR and VEGFR-2 tyrosine kinase inhibitors by in silico high-throughput screening.
    Usui T; Ban HS; Kawada J; Hirokawa T; Nakamura H
    Bioorg Med Chem Lett; 2008 Jan; 18(1):285-8. PubMed ID: 17983745
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fluorophore labeling of the glycine-rich loop as a method of identifying inhibitors that bind to active and inactive kinase conformations.
    Simard JR; Getlik M; Grütter C; Schneider R; Wulfert S; Rauh D
    J Am Chem Soc; 2010 Mar; 132(12):4152-60. PubMed ID: 20201574
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Utilization of microarrayed compound screening (microARCS) to identify inhibitors of p56lck tyrosine kinase.
    Freiberg G; Wilkins J; David C; Kofron J; Jia Y; Hirst GC; Burns DJ; Warrior U
    J Biomol Screen; 2004 Feb; 9(1):12-21. PubMed ID: 15006144
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Method for Assaying the Lipid Kinase Phosphatidylinositol-5-phosphate 4-kinase α in Quantitative High-Throughput Screening (qHTS) Bioluminescent Format.
    Davis MI; Sasaki AT; Simeonov A
    Methods Mol Biol; 2016; 1376():1-9. PubMed ID: 26552670
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluating the utility of a bioluminescent ADP-detecting assay for lipid kinases.
    Vidugiriene J; Zegzouti H; Goueli SA
    Assay Drug Dev Technol; 2009 Dec; 7(6):585-97. PubMed ID: 20035616
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A High-Throughput Radiometric Kinase Assay.
    Duong-Ly KC; Peterson JR
    Methods Mol Biol; 2016; 1360():87-95. PubMed ID: 26501904
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of a novel ectonucleotidase assay suitable for high-throughput screening.
    Sachsenmeier KF; Hay C; Brand E; Clarke L; Rosenthal K; Guillard S; Rust S; Minter R; Hollingsworth R
    J Biomol Screen; 2012 Aug; 17(7):993-8. PubMed ID: 22522649
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A homogeneous and nonisotopic assay for phosphatidylinositol 4-kinases.
    Tai AW; Bojjireddy N; Balla T
    Anal Biochem; 2011 Oct; 417(1):97-102. PubMed ID: 21704602
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-throughput screens for eEF-2 kinase.
    Devkota AK; Warthaka M; Edupuganti R; Tavares CD; Johnson WH; Ozpolat B; Cho EJ; Dalby KN
    J Biomol Screen; 2014 Mar; 19(3):445-52. PubMed ID: 24078616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of a high-throughput screening method for LIM kinase 1 using a luciferase-based assay of ATP consumption.
    Mezna M; Wong AC; Ainger M; Scott RW; Hammonds T; Olson MF
    J Biomol Screen; 2012 Apr; 17(4):460-8. PubMed ID: 22156225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.